PRECLINICAL DEVELOPMENT OF MOXIDECTIN AS A NOVEL THERAPEUTIC FOR ALCOHOL USE DISORDER

Current pharmacotherapies for alcohol used disorder (AUD) are few and relatively ineffective illustrating the need for the development of new, effective medications. Using a translational approach, our laboratory reported that ivermectin, an FDA-approved, human and animal anti-parasitic agent, can s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuropharmacology
Asıl Yazarlar: Huynh, Nhat, Arabian, Natalie, Naito, Anna, Louie, Stan, Jakowec, Michael W., Asatryan, Liana, Davies, Daryl L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5148646/
https://ncbi.nlm.nih.gov/pubmed/27641072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2016.09.016
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller